We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Blood pressure-related diseases kill eight million people a year, mostly in developing countries, yet no major health development fund, development bank or major bilateral aid donor has addressed the problem, according to a comment article in The Lancet.

Similarly, no major international drug company has offered material assistance, "despite gargantuan profits from the sales of blood-pressure-lowering drugs in high-income countries," say Stephen MacMahon and colleagues.

In Africa, there is not a single initiative to implement blood pressure control strategies, even though stroke is rapidly becoming a common cause of death and disability on the continent.

The authors attribute the "staggering inequality" in treatment access to the inability of primary care systems to provide continuing care and the shortsighted view of those who set international health priorities.

They describe the outdated hypertensive care available for huge numbers of people as "a travesty that cannot continue to be ignored".

Link to full article in The Lancet*


*Free registration is required to view this article.

Related topics